Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Ystad – page 24

317 clinical trials in Ystad, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Ystad at a glance
317
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

317 trials in Ystad

Open in trial search

Study on Obinutuzumab, Chlorambucil, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Acerta Pharma B.V.

Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Celgene Corp.

Study Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Janssen Cilag International

Study on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Deucrictibant
  • Sponsor:Pharvaris Netherlands B.V.

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:University Of Cologne

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Malignant melanoma

Not recruiting

Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:MRNA-4157
  • Sponsor:Merck Sharp & Dohme LLC

Breast cancer stage III+3

Not recruiting

Study on Preoperative Treatment for HER2 Positive Breast Cancer Using Docetaxel, Pertuzumab, and Trastuzumab in Patients with Primary Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Karolinska University Hospital

Major depression

Not recruiting

Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine
  • Sponsor:Compass Pathfinder Limited

Renal failure+1

Not recruiting

Study on Dapagliflozin for Kidney Protection in Heart Transplant Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Oslo University Hospital HF

Neoplasm malignant

Not recruiting

Study on BI-1910 and Pembrolizumab for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:BI-1910
  • Sponsor:BioInvent International AB

Study on the Effect of Adding Thoracic Radiotherapy to Durvalumab and Chemotherapy for Patients with Extensive Stage Small-Cell Lung Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Ystad

What the registry says about research in the country

01 Cardiovascular and Emergency Medicine

Innovative research investigating early vasopressor therapy for patients presenting with hypotension in emergency departments. This study aims to improve shock control protocols and potentially reduce intensive care unit admissions.

  • Shock Management
  • Emergency Care Protocols
  • Hemodynamic Support

The research focuses on comparing noradrenaline-based intervention versus traditional fluid therapy approaches.

02 Oncology Research

Studies exploring novel approaches in colorectal cancer treatment, particularly focusing on patients with specific genetic mutations in the PI3K signaling pathway. The research evaluates the potential benefits of acetylsalicylic acid in preventing cancer recurrence.

  • Targeted Cancer Therapy
  • Genetic Mutation Analysis
  • Cancer Prevention

This trial represents a significant step in personalized medicine for colorectal cancer treatment.

03 Nephrology and Cardiology

Clinical investigation examining stroke prevention in patients with chronic kidney disease and atrial fibrillation. The research evaluates the safety and efficacy of anticoagulation therapy in this complex patient population.

  • Stroke Prevention
  • Renal Disease Management
  • Anticoagulation Safety

This study addresses a critical gap in treatment protocols for patients with concurrent kidney and heart conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.